Dupixent and Vancomycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dupixent (dupilumab) and Vancomycin (vancomycin). Common drug interactions include asthma among females and allergy to animal among males.

The phase IV clinical study analyzes what interactions people have when they take Dupixent and Vancomycin. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Dupixent?

Dupixent has active ingredients of dupilumab. eHealthMe is studying from 257,630 Dupixent users. Check the latest studies of Dupixent.

What is Vancomycin?

Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.



On Jul, 06, 2026

24 people who take Dupixent and Vancomycin together, and have interactions are studied.

Dupixent and Vancomycin drug interactions.

What are the common drug interactions of Dupixent and Vancomycin, by gender? *:

female:

  1. Asthma
  2. Injection site reaction
  3. Dyspnoea (difficult or laboured respiration)
  4. Pain in extremity
  5. Urticaria (rash of round, red welts on the skin that itch intensely)
  6. Fatigue (feeling of tiredness)
  7. Pruritus (severe itching of the skin)
  8. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  9. Drug ineffective
  10. Infection

male:

  1. Allergy to animal
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Oral herpes (viral infection of mouth)
  4. Rash
  5. Sleep disorder
  6. Sleep disorder due to a general medical condition
  7. Therapeutic response decreased (less preventive response)
  8. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  9. Fatigue (feeling of tiredness)
  10. Joint swelling

What are the common drug interactions of Dupixent and Vancomycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Hospitalisation
  2. Discomfort
  3. Drug ineffective
  4. Oral herpes (viral infection of mouth)
  5. Rash
  6. Sleep disorder
  7. Sleep disorder due to a general medical condition
  8. Therapeutic response decreased (less preventive response)

10-19:

n/a

20-29:

n/a

30-39:

  1. Injection site reaction
  2. Urticaria (rash of round, red welts on the skin that itch intensely)
  3. Dry eye (lack of adequate tears)
  4. Asthma
  5. Dyspnoea (difficult or laboured respiration)
  6. Fatigue (feeling of tiredness)
  7. Oral infection
  8. Pyrexia (fever)

40-49:

  1. Drug ineffective
  2. Dyspnoea (difficult or laboured respiration)
  3. Fatigue (feeling of tiredness)
  4. Hyperhidrosis (abnormally increased sweating)
  5. Infection
  6. Pain
  7. Pyrexia (fever)
  8. Rash
  9. Skin discomfort (skin pain/irritation)
  10. Skin exfoliation (removal of the oldest dead skin cells)

50-59:

  1. Allergy to animal
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  4. Fatigue (feeling of tiredness)
  5. Joint swelling
  6. Nausea (feeling of having an urge to vomit)
  7. Rhinorrhoea (watery mucus discharge from the nose)
  8. Dyspnoea (difficult or laboured respiration)
  9. Erythema (redness of the skin)
  10. Injection site bruising

60+:

  1. Asthma
  2. Alopecia (absence of hair from areas of the body)
  3. Rash macular (small, flat red spots)
  4. Scratch
  5. Vomiting
  6. Cellulitis (infection under the skin)
  7. Dementia (madness)
  8. Feeling hot
  9. Headache (pain in head)
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 11 people, 45.83%
  2. Asthma: 9 people, 37.50%
  3. Nasal Polyps (masses that develop in the lining of the nose): 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Dupixent and Vancomycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dupixent and Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dupixent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dupixent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vancomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dupilumab and vancomycin (the active ingredients of Dupixent and Vancomycin, respectively), and Dupixent and Vancomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: